The major conclusions of our studies are that blocking chylomicron assembly through conditional deletion of intestinal Mttp mitigates the development of hepatic steatosis in MCD-fed mice and reduces inflammatory and fibrogenic signaling. Here, MTTP is linked to fatty liver disease.